Spotlight on in vitro quantitative assessment of skin sensitizing potency. Join our upcoming webinar to explore the recent advancement in GARD® for quantitative assessment of skin sensitizing potency. This session will present a meta-analysis of GARD® data covering over 200 chemicals, including three blinded datasets generated in collaboration with industry partners. These data will demonstrate […]
Spotlight on Point-of-Departure, Challenging Substances, and Active Ingredients We invite you to join our upcoming webinar, where industry leaders from Lundbeck, Unilever, and Cargill, along with experts from SenzaGen will explain the latest advancements in skin sensitization testing. Join us as we explore the latest data from our GARD® platform on skin sensitization and gain […]
Join us for a special re-run of our popular GARD® webinar to explore the recent advancement in Skin Sensitization testing, focusing on substances that fall outside the applicability domains of the conventional in vitro assays in the OECD Test Guidelines. Our skin sensitization experts will address challenges posed by various "Difficult-to-Test" substances, discussing the applicability […]
Join SenzaGen and industry leaders from Clarins and Bic Skin Creative for an in-depth webinar on using GARD® assays for skin sensitization testing. Learn how this innovative technology overcomes the unique challenges of testing complex Natural Extracts, which often fall outside the scope of traditional methods in OECD 442E Test Guidelines. Through case studies, we will showcase […]
Join us for an insightful webinar on the evolving role of New Approach Methodologies (NAMs) in regulatory biological safety assessments and how they can be used to help develop safe materials in the pre-regulatory space. With shifting standards and increasing adoption of NAMs, understanding their impact is more critical than ever. In this webinar, Dr […]
Advancing NAMs for Skin Sensitization Testing: Natural Extracts, Medical Devices and Potency Join our upcoming webinar, where SenzaGen’s expert and guest speakers from dōTERRA and Risk Science Consortium will share insights and case studies on the use of New Approach Methodologies (NAMs) for skin sensitization assessment. We’ll present the latest GARD® data from our research […]
Bringing high performance and extended applicability to Defined Approaches for Skin Sensitization (DASS) Join our webcast to learn more about the inclusion of GARD®skin in OECD TG 497— what it means and how it can support your regulatory testing strategy. Defined Approaches for Skin Sensitization (DASS) is a key regulatory guideline for combining validated in […]
Using GARD® to derive PoDs and safe dose levels for skin sensitizers Chemicals | Natural Extracts | Complex Mixtures Join our upcoming webinar to explore how GARD® enables the derivation of Points of Departure (PoDs) for Quantitative Risk Assessment (QRA) and helps establish safe dose levels for identified sensitizers. With broad applicability to complex mixtures […]
Bringing high performance and extended applicability to Defined Approaches for Skin Sensitization (DASS) Join us for a special re-run of our popular webcast to learn more about the inclusion of GARD®skin in OECD TG 497 — what it means and how it can support your regulatory testing strategy. Defined Approaches for Skin Sensitization (DASS) is […]
NAMs for skin sensitization ISO 10993-10 Join us for an insightful webinar on the evolving role of New Approach Methodologies (NAMs) in biological safety testing of Medical Devices, with a special focus on skin sensitization – the area currently undergoing the most significant regulatory changes. As ISO standards advance toward reducing animal testing, understanding these […]
